Poxel (LTS:0RA2) Growth Rank : 1 (As of Dec. 15, 2024)

View and export this data going back to 2015. Start your Free Trial

What is Poxel Growth Rank?

Poxel has the Growth Rank of 1.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

Competitive Comparison of Poxel's Growth Rank

For the Biotechnology subindustry, Poxel's Growth Rank, along with its competitors' market caps and Growth Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Poxel's Growth Rank Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Poxel's Growth Rank distribution charts can be found below:

* The bar in red indicates where Poxel's Growth Rank falls into.

Poxel Growth Rank Related Terms

Thank you for viewing the detailed overview of Poxel's Growth Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Poxel Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Poxel SA (LTS:0RA2) » Definitions » Growth Rank

Comparable Companies

Traded in Other Exchanges

POXEL:France 7PO:Germany

Address

259/261 Avenue Jean Jaures, Immeuble le Sunway, Lyon, FRA, 69007

Website

https://www.poxel.com

Poxel SA is a biopharmaceutical company. It is focused on the development of novel treatments for metabolic diseases, including type 2 diabetes and liver diseases, such as nonalcoholic steatohepatitis (NASH) and rare disorders (ALD/AMN). It has developed a portfolio of drug candidates, including its candidates: Imeglimin, for the treatment of type 2 diabetes, and PXL770 and PXL065, for the treatment of NASH.

Poxel Headlines

No Headlines